Foravirumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | rabies virus glycoprotein |
| Clinical data | |
| ATC code | none |
| Identifiers | |
| CAS Number |
944548-38-3  |
| ChemSpider | none |
| UNII |
377VY97V7S  |
| ChEMBL |
CHEMBL1743021 |
| Chemical and physical data | |
| Formula | C6400H9914N1718O1998S44 |
| Molar mass | 144.3 kg/mol |
| (what is this?) (verify) | |
Foravirumab is a monoclonal antibody for the prophylaxis of rabies.[1] It is under development by Sanofi/Crucell.[2]
References
- ↑ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
- ↑ Khardori, Nancy Misri (2011). Biologic Response Modifiers in Infectious Diseases, An Issue of Infectious Disease Clinics. London: Elsevier Health Sciences. p. 158. ISBN 9781455712076.
This article is issued from Wikipedia - version of the 10/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.